Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential information.
This move was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman later explained that the US was demanding access to health data for research and commercial gain but refused to share the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued dialogue to secure a agreement agreeable to both sides so the country's vital HIV treatment initiative can continue.
Wider Background
This development follows a similar case in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' medical information.
Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
According to reports, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," his statement read.
"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems already established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but suggested that negotiations need to persist since much of the nation's HIV programmes relied on external financing.
"In cases where technical issues exist, including those relating to information security or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
This impasse emphasises the ongoing debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.